Alan Wilson

82 papers receiving 3.5k citations

Alan Wilson's Hit Papers

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 1998 · 1.2k citations
1.2k0+9+18Years since publication4008001.2k

Peers

Alan Wilson
Comparison fields: 5 of 133
  • Endocrinology, Diabetes and Metabolism 906
  • Cardiology and Cardiovascular Medicine 782
  • Pharmacology 283
  • Nephrology 167
  • Pharmacology 312
Replace Hideaki Kaneto with:
Hideaki Kaneto Japan
Katsumi Ikeda Japan
Pitchai Balakumar India
Naoto Katakami Japan
Shui‐Ping Zhao China
Günther Jürgens Austria
Taka‐aki Matsuoka Japan
Anthony Zulli Australia
Luciano Cominacini Italy
Vaijinath S. Kamanna United States
Alan Wilson relative to Hideaki Kaneto Japan Hideaki Kaneto's profile →
Citations per field
00.5×2×2.7×
Hideaki Kaneto · 1×
Citations per year

Countries citing papers authored by Alan Wilson

Since Specialization
Citations

This map shows the geographic impact of Alan Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Wilson more than expected).

Fields of papers citing papers by Alan Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Wilson. The network helps show where Alan Wilson may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Wilson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Wilson Line = papers co-authored together Alan Wilson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
Hit paper breakdown →
19981201
2 2012211
3 2004149
4 1989145
5 2008138
6 2010103
7
Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.
198176
8 201672
9 200972
10 200971
11 200970
12 199662
13 201761
14 200861
15 196957
16 201455
17 199248
18 199048
19
Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
198147
20 201447

About Alan Wilson

Alan Wilson is a scholar working on Pharmacology, Cancer Research, Endocrinology, Diabetes and Metabolism, Computational Theory and Mathematics and Small Animals, having authored 83 papers that have together received 3.8k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (14 papers), Computational Drug Discovery Methods (12 papers), Pharmacogenetics and Drug Metabolism (10 papers), Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Animal testing and alternatives (6 papers) and Analytical Chemistry and Chromatography (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (906 citations), Cardiology and Cardiovascular Medicine (782 citations), Pharmacology (283 citations), Nephrology (167 citations) and Pharmacology (312 citations). Alan Wilson has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Linda J. Loretz, Albert P. Li, M. Wayne Flye, Mehdi Boroujerdi, David R. Powell, Marshall W. Anderson, Bryce A. Harrison, Marshall W. Anderson, Faika Mseeh and Brian Zambrowicz. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Future Medicinal Chemistry and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact